Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Is Areds 2 Supplement Good for AMD?
AMD stands for age-related macular degeneration and it is an eye disease where your vision is blurred. Using Areds 2 supplement depends on the stage you have the blurry vision either early intermediate or late. Also depending on AMD in…
Peters Anomaly: Causes, Symptoms and Management
What Is Peters Anomaly? Peters anomaly is a rare congenital ocular condition primarily affecting the anterior segment of the eye. At its core, it’s characterized by the abnormal development of the cornea’s central layers and potential adhesions between the cornea…
Corneal Staining: Causes, Symptoms and Management
Corneal staining is a critical concept in the field of eye health, referring to a condition where the cornea, the clear front surface of the eye, becomes stained or discolored. This phenomenon is particularly significant because it often indicates underlying…
RVL Launches Prescription E-Commerce Platform
RVL Pharmaceuticals recently introduced a proprietary prescription e-commerce platform known as ELEVATE. This platform aims to provide a hassle-free and secure subscription service that offers a seamless and efficient solution for purchasing RVL products for both healthcare providers and patients.…
Study Estimates $5.2M Cost of Vision Loss in Australia
In a groundbreaking study published in the Medical Journal of Australia, researchers have quantified the lifetime cost of living with an inherited eye disease in Australia, revealing it to be $5.2 million per person. Shockingly, a significant portion of these…
EVMANN Takes Two Innovative Companies Under its Umbrella
AMSTERDAM, Oct. 5, 2021 /PRNewswire/ — Within framework of global growth strategy implemented in early 2021, VSY Biotechnology GmbH-Germany and Alsanza Medizintechnik und Pharma GmbH-Germany companies which manufacture and sell their innovative products in ophthalmology and orthopedy fields over 90 countries and 6 continents have decided to…
Dysthyroid Optic Neuropathy and Its Management
Dysthyroid optic neuropathy (DON) is a condition that arises from the complex interplay between thyroid dysfunction and ocular health. Often associated with autoimmune thyroid disorders such as Graves’ disease, DON can lead to significant vision impairment and impact an individual’s…
New Case Study Seeks to Enhance Perspectives in International Ophthalmology Partnerships – CU Anschutz newsroom
New Case Study Seeks to Enhance Perspectives in International Ophthalmology Partnerships CU Anschutz newsroom Source: Author: | Date: 2024-10-21 07:00:00 Source: Author: | Date: 2024-10-21 07:00:00
Glaucoma Market to Grow to $3.5 Billion by 2030
According to GlobalData, the glaucoma market across the seven major markets* is predicted to grow steadily from $2.8 billion in 2020 to $3.5 billion in 2030, with a compound annual growth rate (CAGR) of 2%. According to the latest analysis…
Methylsulfonylmethane Eye Drops Contaminated, FDA Warn
The FDA has issued warning to consumers, advising them against purchasing and immediately discontinuing the use of two products: Dr. Berne’s MSM Drops 5% Solution and LightEyez MSM Eye Drops – Eye Repair. The warning is based on the potential…